Quarterly Results
CTRE Earnings Forecast
Looking ahead, CTRE remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q2 project quarter revenue of 110.20M and an EPS of undefined.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming , revenue estimates have been adjusted Go Up by 8.65% . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in CTRE long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
1Y
3Y
5Y
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Al Analysis
Earnings Surprise Analysis
Revenue
EPS
1Y
3Y
Al Analysis
Earnings Reaction
The chart below shows how CTRE performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CTRE sees a -2.33% change in stock price 10 days leading up to the earnings, and a -0.07% change 10 days following the report. On the earnings day itself, the stock moves by +0.85%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -1.22% on the day following the earnings release and then changed by 1.50% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
People Also Watch
Frequently Asked Questions
What were the key highlights of CTRE's latest earnings report for ?
CTRE reported its earnings on 2025-11-05, showcasing a revenue of 132.44M against an estimate of 131.03M, resulting in a 1.08% surprise. The EPS was 0.45, surpassing the expected 0.47 by -4.26% . The stock experienced a -1.22% price change on the earnings day and a 1.39% change over the next five days, reflecting market reactions to the results.
How did CTRE's stock price react after the earnings release?
Following CTRE's earnings announcement on 2025-11-05, the stock price moved by -1.22% on the day of the release. Over the subsequent five days, it saw a 1.39% change. Historically, CTRE's stock price tends to shift by an average of -2.33% in the 10 days leading up to earnings and -0.07% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for CTRE for 2025/Q2?
For 2025/Q2, analysts estimate CTRE’s annual revenue to reach 110.20M, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Go Up by 8.65% over the past three months, indicating analyst expectation in the company’s performance.
How does CTRE's stock price correlate with earnings forecast revisions?
The correlation between CTRE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved Go Up by 8.65% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from CTRE's next earnings report?
Based on historical trends, CTRE's stock price typically moves by -2.33% in the 10 days before its earnings and -0.07% in the 10 days after. For the upcoming 2025/Q2 earnings, analysts expect an EPS of undefined and revenue of 110.20M.
What is the sentiment in CareTrust REIT Inc (CTRE) Q3 2025 Earnings Call Summary?
The earnings call summary and Q&A reveal strong financial performance, strategic market expansion, and optimistic guidance. Financial metrics are robust, with low net debt to enterprise value and high fixed charge coverage ratio. The raised guidance for 2025, active U.K. market expansion, and strategic SHOP investments are positive indicators. While some concerns exist, such as the slight decline in U.K. care home coverage, overall sentiment is positive. Given the market cap, the stock price is likely to experience a positive movement, between 2% to 8%, over the next two weeks.

